Day 1 - Wednesday 30th November 2016

---

• How can you use the ‘power of data’ to improve your pharmaceutical manufacturing process?
• Understanding where to prioritise capturing real-time data within the manufacturing process
• How to cloud storage to collect and handle large volumes of data?
• Exploring how to use data analytics to gain useful insight and outcomes from your data collection?
• How can you use predictive analytics to improve your process and manage risk?
• Ensuring generated data is protected to meet data integrity regulatory requirements?
• Creating a procedure to internally assess the software you have in place to handle the data?
• How to ensure your process does not impact negatively on product quality?
• How can pharma companies work with CMOs to exchange information and create a fully visible data collection and analytics process?
• What are the future possibilities of connecting pharma manufacturing data to mobile apps, and will this be accepted by the regulators?

---

An exciting insight into the future possibilities of Industry 4.0 and their own perspective on what this could mean for pharma manufacturing professionals.

• To what extent will the ‘Internet of Things’ meet the regulatory requirements for data integrity?
• How will the process ultimately connect to the packaging, distribution and patient?
• What is the potential for adding robotics to the pharma manufacturing process - how can this link into your existing manufacturing platform?
• How to prioritise what data to collect, and how can it be stored and use?
• How to implement adaptive learning – and ensure intelligent decisions are made based on data collected?
• What are the possibilities of self-learning systems and how can they be implemented in a pharma manufacturing process?
• How can you minimise the risk and reduce complexity in the validation process?
• How can you convince key stakeholders – including the board and business platform leaders that Industry 4.0 is worth investing in – what is the business value and business case?

---

---

---

---

---

---

---

---

This interactive session provides the opportunity to pick your specific focus area to discuss with peers in a small group of 10. Don’t miss this fantastic chance to solve your issues and make important new contacts with senior-level pharma manufacturing professionals.

Round table 1: What are the predictions for pharma products 2030? Marco Maioli, Industrial Operations Director, Sigma-Tau

Round table 2: Biologics - Anne Tolstrup, Senior Manager Manufacturing Sciences, Biogen

Round table 3: High-Value / Small volume - Frédéric Zwahlen, Vice President, Head of Pharmaceutical Manufacturing, Vifor Pharma

Round table 4: Parenterals / injectables – Enrico Sibani, Supply Chain and Distribution for GMS Italy, BMS

---

---

---

---

• How can you effectively transition technology into the commercial environment?

• How to set up effective communication between R&D, operations and commercial teams to ensure the smooth transition of technology

• How can you set up a flexible team to redirect sources as and when they are needed

• How to ensure that the original concept of the brand new innovative technology is not lost during scale up

• How to set up a plan to continue to support the sites as a tech services team

---

---

---

---

Revel the ambience of the season, enjoy a glass of mulled wine, taste some traditional grilled sausages and other tasty snacks. Let our drinks reception at the end of the first day conjure the magic of a traditional German Christmas Market whilst catching up with old colleagues and developing new contacts.